GlassScriptPhysician profile
Carly P Scatton
NPI 1801158464
$6,393.68
in general payments reported to CMS, 2019-2025
51 companies · $37.67 in 2025
The $37.67 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,975 · 2020: $607 · 2021: $822 · 2022: $1,365 · 2023: $1,082 · 2024: $505 · 2025: $37.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,624.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $735.43 | 2021-2024 | Ubrelvy, Qulipta, Botox |
| Novartis Pharmaceuticals Corporation | $476.30 | 2019-2024 | |
| Biogen, INC. | $404.01 | 2019-2024 | Vumerity, Tysabri, Plegridy |
| Teva Pharmaceuticals USA, INC. | $358.04 | 2019-2022 | |
| Csl Behring | $323.87 | 2019-2024 | Hizentra |
| Amgen INC. | $308.24 | 2019-2022 | |
| Genzyme Corporation | $262.67 | 2019-2022 | |
| Ucb, INC. | $249.86 | 2019-2022 | |
| Emd Serono, INC. | $245.73 | 2019-2024 | Mavenclad |
| Argenx US, INC. | $220.66 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
| Acadia Pharmaceuticals INC | $211.12 | 2019-2022 | |
| Abbott Laboratories | $205.74 | 2019-2023 | Infinity |
| Allergan, INC. | $198.26 | 2019-2022 | |
| Genentech USA, INC. | $178.38 | 2019-2024 | Ocrevus |
| Acorda Therapeutics, INC | $173.08 | 2019-2024 | Inbrija |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carly Scatton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.